These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10905274)

  • 1. Can growth hormone therapy cause diabetes? KIMS Strategic Committee.
    Monson JP; Bengtsson BA; Abs R; Feldt-Rasmussen U; Wüster C
    Lancet; 2000 May; 355(9216):1728-9. PubMed ID: 10905274
    [No Abstract]   [Full Text] [Related]  

  • 2. Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults.
    Oliveira JL; Aguiar-Oliveira MH; D'Oliveira A; Pereira RM; Oliveira CR; Farias CT; Barreto-Filho JA; Anjos-Andrade FD; Marques-Santos C; Nascimento-Junior AC; Alves EO; Oliveira FT; Campos VC; Ximenes R; Blackford A; Parmigiani G; Salvatori R
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4664-70. PubMed ID: 17911170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency.
    Janssen YJ; Helmerhorst F; Frölich M; Roelfsema F
    J Clin Endocrinol Metab; 2000 Jan; 85(1):464-7. PubMed ID: 10634425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity to growth hormone-the perspective. Round table discussion.
    Monson JP; Rosenfeld RG
    Horm Res; 2001; 55 Suppl 2():65-7. PubMed ID: 11684880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth-hormone treatment and risk of diabetes.
    Fukui M; Nakamura N; Kondo M
    Lancet; 2000 May; 355(9218):1912-3; author reply 1913-4. PubMed ID: 10866470
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
    Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
    Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can growth hormone therapy cause diabetes?
    Jeffcoate W
    Lancet; 2000 Feb; 355(9204):589-90. PubMed ID: 10696973
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin-like growth factor-I in the therapy of non-insulin-dependent diabetes mellitus and insulin resistance.
    Froesch ER; Bianda T; Hussain MA
    Diabetes Metab; 1996 Jul; 22(4):261-7. PubMed ID: 8767173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety aspects of GH replacement.
    Svensson J; Bengtsson BA
    Eur J Endocrinol; 2009 Nov; 161 Suppl 1():S65-74. PubMed ID: 19684054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose effects of growth hormone during puberty.
    Saenger P
    Horm Res; 2003; 60(Suppl 1):52-7. PubMed ID: 12955018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abdominal lipohypertrophy caused by injections of growth hormone: a case report.
    Ruvalcaba RH; Kletter GB
    Pediatrics; 1998 Aug; 102(2 Pt 1):408-10. PubMed ID: 9714655
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth hormone therapy in short children born small for gestational age.
    Ong K; Beardsall K; de Zegher F
    Early Hum Dev; 2005 Dec; 81(12):973-80. PubMed ID: 16271835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
    Bengtsson BA; Abs R; Bennmarker H; Monson JP; Feldt-Rasmussen U; Hernberg-Stahl E; Westberg B; Wilton P; Wüster C
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis and the growth hormone-insulin-like growth factor axis.
    Geusens PP; Boonen S
    Horm Res; 2002; 58 Suppl 3():49-55. PubMed ID: 12435898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons learned from 15 years of KIMS and 5 years of ACROSTUDY.
    Luger A; Feldt-Rasmussen U; Abs R; Gaillard RC; Buchfelder M; Trainer P; Brue T
    Horm Res Paediatr; 2011; 76 Suppl 1():33-8. PubMed ID: 21778746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone and cardiovascular disease: an area in rapid growth.
    Thomas AM; Berglund L
    J Clin Endocrinol Metab; 2001 May; 86(5):1871-3. PubMed ID: 11344174
    [No Abstract]   [Full Text] [Related]  

  • 20. [Growth hormone and bone].
    Salles JP
    Arch Pediatr; 2006 Jun; 13(6):666-8. PubMed ID: 16697612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.